2m 2m 2m 2m 2m 2m 2m
Viking Therapeut (VKTX)
NASDAQ
$29.98-$0.54 (-1.75%)
Price as of Oct 02, 2026 6:15 PM EDT- $3.8BMarket Cap
- 9.43%1-Year Change
- BiotechnologyIndustry
Viking Therapeut (VKTX)
$29.98-$0.54 (-1.75%)
VKTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.51 | ||
Change | -$2.09 (-6.41%) | ||
Open | $31.92 | ||
High | $32.48 | ||
Low | $30.43 | ||
Previous Close | $32.60 | ||
Volume | 6,873,868 | ||
30-Day Average Volume | 7,331,644 | ||
1-Week Change | -16.98% | ||
1-Month Change | -9.39% | ||
1-Year Change | 9.43% | ||
3-Year Change | 175.61% | ||
5-Year Change | 396.91% | ||
Fundamentals | |||
Shares Outstanding | 125.7M | ||
Total Assets | $521.9M | ||
Market Cap | $3.8B | ||
Enterprise Value | $3.7B | ||
Period: QTR TTM FY | |||
Revenue | $30,000.00 | ||
Net Income | -$128.0M | ||
Free Cash Flow | -$125.2M | ||
EBIT | -$128.0M | ||
EBITDA | -$128.0M | ||
Net Working Capital | $407.9M | ||
EPS | -$1.10 | ||
Enterprise Value/EBITDA | -29 | ||
Enterprise Value/Revenue | 123,634 | ||
P/B | 9 | ||
P/E | -28 | ||
PEG | -1 | ||
Price/Free Cash Flow | -31 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue